confirmed clinical diagnosis of t2dm with a hemoglobin a1c (hba1c) of ≥ 6.5%; and

male or female between the ages of 21-85 years old; and

willingness to be randomized to either treatment or control groups.

is or was on renal dialysis;

experiencing an acute or terminal illness or serious mental illness;

had a history of recent coronary event within the last 3 months of recruitment;

is pregnant at the time of recruitment;

experienced other severe medical conditions that might preclude participation;

has poor short-term prognosis (expected death in <2 years); or

is participating in another research study.